- The new variant Omicron now accounts for over 70% of new cases in Morocco. The first case of Omicron was reported only a few days back. Compared to 100 cases in December, Morocco is now recording some 6000 cases daily.
- The Ministry Of Health of Morocco has said that the peak of the new wave is expected within two weeks.
The new variant Omicron now accounts for over 70% of new cases in Morocco. The first case of Omicron was reported only a few days back. Compared to 100 cases in December, Morocco is now recording some 6000 cases daily. The Ministry Of Health of Morocco has said that the peak of the new wave is expected within two weeks.
Meanwhile, the Ministry of Health and Social Protection of Morocco has approved the emergency use of Molnupiravir the antiviral drug developed by the US pharmaceutical company Merck, for treatment of COVID-induced acute respiratory illnesses. According to the Health Ministry, the drug was approved after due diligence after samples of this drug were analyzed by the national drug control laboratory. The Ministry added that it has proved to be effective and reduces the risk of severity and deaths by 50%, especially if administered within the first five days of infection. Several countries including the UK, the United States, and Japan have already authorized this drug for the treatment of COVID-19 patients.
The ministry, she recalls, urges citizens to complete their vaccination schedule and comply with preventive measures to curb the spread of the virus, especially the Omicron variant which spreads very quickly. The U.S. Food and Drug Administration has already issued an emergency use authorization (EUA) for Merck’s Molnupiravir for the treatment of mild-to-moderate coronavirus disease.
